Peconic Genomics

Peconic Genomics operates as a niche contract research organization (CRO) focused on high-resolution epigenomic mapping services. Leveraging the proprietary ChIP-exo technology invented by its founder, the company provides end-to-end services from sample processing to bioinformatics analysis, primarily for academic researchers. Its business model is built on a fee-for-service basis with a low-cost validation option to de-risk experiments for clients. Peconic aims to be an essential partner in foundational epigenomics research, which has broad implications for personalized medicine and drug development.

Proprietary ChIP-exo assay for high-resolution mapping of protein-DNA interactions, coupled with optimized ChIP-seq and bioinformatics analysis services.

Peconic competes in the niche epigenomics services market against other specialized CROs and academic core facilities. Its primary competitive advantage is its founder's association with the ChIP-exo invention and its focused expertise. Broader competition includes large genomics service providers offering standard ChIP-seq, but they typically lack the same depth of specialization in high-resolution ChIP-exo.